Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Phase 3, Open-Label, Multicenter Safety Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (MT-1186-A01): 48-Week Results

Author:Genge, Angela   Pattee, Gary   Sobue, Gen   Couratier, Philippe   Selness, Daniel   Bidani, Sachin   Hirai, Manabu   Sakata, Takeshi   Salah, Alejandro   Apple, Stephen   

Session Name:P6: General Neurology: New Treatments  

Topic:General Neurology  

Program Number:P6.001  

Author Institution:Montreal Neurological Institute and Hospital, Montreal, QC, Canada  University of Nebraska Medical Center, Lincoln, NE  Nagoya University Graduate School of Medicine, Nagoya, Japan  CRMR SLA Service de Neurologie, CHU de Limoges, Limoges, France  Mitsubishi Tanabe Pharma Development America, Inc. , Jersey City, NJ  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  

Effects of ocrelizumab on NK cell activation in Relapsing Multiple Sclerosis

Author:Abbadessa, Gianmarco   Bruzzaniti, Sara   Miele, Giuseppina   Piemonte, Erica   Lepore, Maria Teresa   Signoriello, Elisabetta   Lus, Giacomo   Matarese, Giuseppe   Galgani, Mario   Bonavita, Simona   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P3.004  

Author Institution:University of Campania Luigi Vanvitelli, Naples, Italy  University of Naples Federico II, Naples, Italy  University of Campania Luigi Vanvitelli, NA - Napoli, Italy  

Effects of Ozanimod on Cognitive Processing Speed: Findings From the Phase 3 SUNBEAM and DAYBREAK Extension Trials

Author:DeLuca, John   Cohen, Jeffrey A.   Cree, Bruce A. C.   Cheng, Chun-Yen   Sheffield, James K.   Riolo, Jon V.   Silva, Diego   Comi, Giancarlo   Kappos, Ludwig   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.001  

Author Institution:Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, West Orange, NJ  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, San Francisco, CA  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Vita-Salute San Raffaele University, and Casa di Cura del Policlinico, Milan, Italy, Milan, Italy  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  

Telehealth Equivalence of the Montreal Cognitive Assessment (MoCA): Results from the Emory Healthy Brain Study (EHBS)

Author:Loring, David   Lah, James   Goldstein, Felicia   

Session Name:P6: Aging and Dementia: Innovation in Cognitive and Functional Assessments  

Topic:Aging and Dementia  

Program Number:P6.001  

Author Institution:Emory University School of Medicine, Atlanta, GA  

Investigating Black/African-American Medical Student Interest in Neurology as a Profession

Author:Maddy, Krisna   Ezeh, Uche C.   Sacco, Ralph   Monteith, Teshamae   

Session Name:P6: Education, Research and Methodology: Diversity, Equity, and Inclusion Pertaining to Students and Neurology Residents  

Topic:Education, Research, and Methodology  

Program Number:P6.001  

Author Institution:University of Miami Miller School of Medicine - - Miami, FL, Miramar, FL  University of Miami Miller School of Medicine - - Miami, FL, Miam, FL